FDA Adverse Event Injury Summary report: N

REFLEXION X1

MDR report key: 13006612 · Received December 14, 2021

Report

Report Number
3011716550-2021-00001
Event Type
Injury
Date Received
December 14, 2021
Date of Event
October 31, 2021
Report Date
November 15, 2021
Manufacturer
REFLEXION MEDICAL, INC.
Product Code
MUJ
UDI-DI
00860003983805
PMA / PMN Number
K190978
Removal / Correction Number
3011716550-12/9/21-001-C
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

REFLEXION HAS INVESTIGATED THE ISSUE AND DETERMINED THE CAUSE TO BE A CODE IMPLEMENTATION DEFECT IN THE TREATMENT PLANNING SOFTWARE. WHEN REFLEXION'S TREATMENT PLANNING SYSTEM CALCULATES DOSE, AN ACCURATE ORIENTATION FOR IMAGE, DOSE, PRIMARY BEAM, AND SCATTER ORIENTATION (DOSE ANGLES) IS NECESSARY. THE SCATTER ORIENTATION IN THE DOSE CALCULATION ALGORITHM IS INCORRECT FOR ANY PATIENT ORIENTATION OTHER THAN HEAD FIRST SUPINE (HFS). THE OTHER PATIENT ORIENTATIONS ARE HEAD FIRST PRONE (HFP), FEET FIRST PRONE (FFP), AND FEET FIRST SUPINE (FFS). TREATMENT PLANS FOR HFS ARE NOT AFFECTED.

Description of Event or Problem · 0

PATIENT (B)(6) RECEIVED 22 OUT OF 25 PLANNED FRACTIONS FOR PROSTATE BED + LYMPH NODE ON THE REFLEXION X1 SYSTEM, AND 3 ADDITIONAL FRACTIONS ON ANOTHER SYSTEM. DURING THE COURSE OF HIS TREATMENT, THE PATIENT RECEIVED AN OVERDOSE TO THE PTV OF 7.8%, EXCEEDING CLINICAL TREATMENT GOALS. THERE WERE ASSOCIATED OVERDOSES TO ORGANS AT RISK (OARS). THE ADDITIONAL DOSE TO THESE ORGANS MAY RAISE THE RISK OF SHORT-TERM OR LONG-TERM INJURY BEYOND KNOWN BASELINE RISKS OF PROSTATE BED RADIOTHERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1894810 REFLEXION X1 REFLEXION MEDICAL RADIOTHERAPY SYSTEM MUJ REFLEXION MEDICAL, INC. RXM1000 NA 00860003983805

Patients

Seq Age Sex Outcome Treatment
1 Prefer Not To Disclose Other